Smart multifunctional GLA-nanoformulation for Fabry disease

Informations projet

Smart-4-Fabry

N° de convention de subvention: 720942

DOI 10.3030/720942

Projet clôturé

Date de signature de la CE 22 Novembre 2016

Date de début 1 Janvier 2017

Date de fin 31 Decembre 2020

Financé au titre de

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies

Coût total € 5 844 508,63

Contribution de l’UE € 5 844 508,63

Coordonné par

CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P.
Spain

Livrables

Documents, reports (4)

Linkedin, Youtube, Twitter

Feeding and reporting activities of the social communities

Press and social media repercussion

Report on press appearances and social media repercussion

Use and dissemination Plan

Report defining the activities related to the use and dissemination of the project's results

Compilation of scientific papers published

Report with a Compilation of the scientific papers published during the project

Other (2)

Smart-4-Fabry Final Expo
Project/group presentations

Group presentation/special seminar at appropriate pharmaceutical conference

Websites, patent fillings, videos etc. (1)

Smart-4-Fabry public website

Development and follow-up of a website with the information/activities of the project

Publications

Peer reviewed articles (2)

Synthesis of Stable Cholesteryl–Polyethylene Glycol–Peptide Conjugates with Non-Disperse Polyethylene Glycol Lengths

Auteurs: Edgar Cristóbal-Lecina, Daniel Pulido, Pau Martin-Malpartida, Maria J. Macias, Fernando Albericio, Miriam Royo
Publié dans: ACS Omega, Numéro 5/10, 2020, Page(s) 5508-5519, ISSN 2470-1343
Éditeur: ACS Publications
DOI: 10.1021/acsomega.0c00130

Impact of Chemical Composition on the Nanostructure and Biological Activity of α-Galactosidase-Loaded Nanovesicles for Fabry Disease Treatment

Auteurs: Judit Tomsen-Melero, Solène Passemard, Natalia García-Aranda, Zamira Vanessa Díaz-Riascos, Ramon González-Rioja, Jannik Nedergaard Pedersen, Jeppe Lyngsø, Josep Merlo-Mas, Edgar Cristóbal-Lecina, José Luis Corchero, Daniel Pulido, Patricia Cámara-Sánchez, Irina Portnaya, Inbal Ionita, Simó Schwartz, Jaume Veciana, Santi Sala, Miriam Royo, Alba Córdoba, Dganit Danino, Jan Skov Pedersen,
Publié dans: ACS Applied Materials & Interfaces, 2021, ISSN 1944-8244
Éditeur: American Chemical Society
DOI: 10.1021/acsami.0c16871

Droits de propriété intellectuelle

Patent (3)

ES: “LIPOSOMAS FUNCIONALIZADOS ÚTILES PARA LA LIBERACIÓN DE COMPUESTOS BIOACTIVOS”.INT: “FUNCTIONALIZED LIPOSOMES USEFUL FOR THE DELIVERY OF BIOACTIVE COMPOUNDS”

Numéro de demande/publication: ES P201231020
Date: 2012-06-29

ES: “LIPOSOMAS FUNCIONALIZADOS ÚTILES PARA LA LIBERACIÓN DE COMPUESTOS BIOACTIVOS”.INT: “FUNCTIONALIZED LIPOSOMES USEFUL FOR THE DELIVERY OF BIOACTIVE COMPOUNDS”

Numéro de demande/publication: ES P201231020
Date: 2012-06-29

ES: “LIPOSOMAS FUNCIONALIZADOS ÚTILES PARA LA LIBERACIÓN DE COMPUESTOS BIOACTIVOS”.INT: “FUNCTIONALIZED LIPOSOMES USEFUL FOR THE DELIVERY OF BIOACTIVE COMPOUNDS”

Numéro de demande/publication: ES P201231020
Date: 2012-06-29
Demandeur(s): FUNDACIO PARC CIENTIFIC DE BARCELONA